Key points of the DANPACE II study on atrial pacing and atrial fibrillation in sinus node dysfunction: 1. Minimizing atrial pacing in pacemakers doesn't prevent atrial fibrillation (AF): • 46% of patients regardless of pacing rate (40bpm or 60bpm) experienced an AF episode lasting over 6 minutes during 2 years. • No difference in AF rates across age, heart rhythm patterns, or prior AF history. 2. Safety concerns: Lower pacing rate linked to increased presyncope/syncope (22% vs 13%). • Some patients initially assigned to 40bpm required device reprogramming to a higher rate due to these issues. 3. Standard pacing settings (60bpm with rate-adaptive pacing) are recommended unless individual needs require adjustment. • Rate-adaptive pacing adjusts to activity level, providing adequate heart rate while minimizing unnecessary atrial pacing. 4. Optimal pacing rate remains under investigation for further minimizing AF and syncope. • Future studies are needed to identify specific patient groups who might benefit from atrial pacing minimization. 5. Overall, DANPACE II clarifies pacemaker programming strategies for sinus node dysfunction patients. • While minimizing atrial pacing isn't generally effective for preventing AF, the study provides valuable insights for optimizing pacemaker settings to ensure patient safety and well-being. Link to article: https://doi.org/10.1093/eurheartj/ehad564

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related